3rd Quarter - Report
WILEY REIN LLP for FRESENIUS KABI USA LLC
Firm
Client
Income
$10,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
H.R.3269/S.2276, Eliminating Thickets to Increase Competition (ETHIC) Act H.R.6485/S.43, Skinny Labels, Big Savings Act Issues related to pharmaceutical manufacturing Issues related to pharmaceutical patents
Foreign entity interest: As the ultimate parent entity of Fresenius Kabi USA LLC, Fresenius Kabi SwissBioSim GmbH, disclosed on the LD-1, has an interest in the issues above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KARIN HESSLER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.